Mitoxantrone Completed Phase 2 Trials for Myelodysplastic Syndromes (MDS) / Leukemias Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00015951Bevacizumab, Cytarabine, and Mitoxantrone on Treating Patients With Hematologic Cancers